Newsroom
AstraZeneca Investing in Blood Test to Personalize NSCLC Treatment
AstraZeneca has signed up Roche and Qiagen to develop two separate diagnostic tests, both using simple blood samples, to identify patients who will benefit from its lung cancer drugs.
US Paves Way for Novartis to Copy Amgen Biotech Drug
U.S. regulators have accepted an application by Sandoz - the generics arm of Novartis - seeking approval for a copycat version of Amgen's drug Neupogen, or filgrastim, for patients with low white blood cell counts.
Innovative Approaches by Pharmacists Save Costs at a Comprehensive Cancer Center
Active implementation of cost-saving measures successfully cut down expenditure at the Norris Comprehensive Cancer Center.
Without Medicaid,Hospitals May Pay Patient Premiums
Uncompensated care was supposed to be a thing of the past, but it's persisting in many states not expanding Medicaid eligibility. As an alternative, for some high-cost uninsured patients, hospitals are turning to a new option.
For Better Treatment, Doctors And Patients Share The Decisions
When weighing the risk of heart disease, how the numbers are presented to patients can make all the difference.
Care Coordination Pilot Looks to Prevent Hospital Readmissions
The University of Buffalo is working to limit patient readmissions to hospitals and ERs via use of dashboard technology.
BMS Announces Collaboration With Ono Pharmaceutical to Market Opdivo
Opdivo (Nivolumab) recently received regulatory approval in Japan for the treatment of patients with unresectable melanoma, the first global approval for a PD-1 inhibitor.
CDC Lab Safety Point Person, Dr. Michael Bell, to Give Keynote on Hospital Safety at AJMCLive Event
Dr. Michael Bell, previously announced as the keynote speaker for the September 25-26 live meeting hosted by The American Journal of Managed Care, this weekend discussed his role in overhauling lab safety at the Centers for Disease Control and Prevention in Atlanta. Attendees at AJMCLive’s Atlanta conference, “Value-Based Decision-Making in Infectious Disease,” will have the chance to hear Dr. Bell discuss the prevention of hospital-acquired infections.
ACO, Health Insurance Exchange Pressures Mounting
As healthcare reform advances, experts say, dermatologists face mounting pressure to prove their mettle to insurance exchanges and accountable care organizations (ACOs).
Medical-Loss Ratio Prompted Insurers to Refund $332 Million Last Year
A federal rule requiring health insurers to spend a minimum percentage of premium dollars on medical care led to more than $332 million in rebates last year, according to HHS.
Robotics Do Not Reduce Complications in Bladder Surgery
Following the success of robotics in prostate surgeries, the technique was expected to provide comparable results for bladder cancer surgeries as well.
Gilead's Idelalisib Approved for CLL and Lymphoma
The drug has been approved for use in patient's with relapsed disease.
Cost-Conscious Payers Are Eyeing Higher Prices on Diabetes Drugs
With diabetes costs taking double-digit increases--and expensive newer meds launching--insurers are tightening restrictions on drug use.
Specialists See Little Change in Compensation, Survey Finds
According to a recent survey, radiation oncologists are doing this for 7.9% less pay than they earned the year before.
NICE Approves Xtandi and Yervoy
The approval is a big gain for melanoma (Yervoy) and prostate cancer (Xtandi) patients in England and Wales.
Entecavir Falls Short of Protecting Hep B-infected Patients from HCC
However, a point to note is that this was a small cohort study without a comparator arm.
Appeals Courts Disagree Over Obamacare
Obamacare got taken for a roller-coaster ride on Tuesday when two different appeals courts took completely different takes on the latest challenges to the law.
HHS Reissues Dsputed 340B Policy on Orphan-Drug Discounts
HHS issued an interpretive rule that requires drug companies to provide discounts on orphan drugs sold through a federal program just months after a judge struck down the government's previous version of the rule.
AJMC Study Finds Medicaid Barriers to the Right Drugs May Cause More with Schizophrenia to Land Behind Bars
A study in The American Journal of Managed Care finds Medicaid prior authorization requirements for newer antipsychotic drugs are associated with an increased likelihood that individuals with schizophrenia will be incarcerated for nonviolent drug offenses. The study comes amid media scrutiny over whether cutbacks in mental health actually save money, when other costs are taken into account.
IT, Patient-Centered Research Key to Pushing Disease Prevention Efforts
Information technology will be crucial to pushing disease prevention efforts in healthcare.
To Prevent Surprise Bills, New Health Law Rules Could Widen Insurer Networks
The Obama administration and state insurance regulators are developing stricter standards to address the concerns of consumers who say that many health plans under the Affordable Care Act have unduly limited their choices of doctors and hospitals, leaving them with unexpected medical bills.
Breakthrough Therapy Designation for Aduro's Immunooncology Combination for Pancreatic Cancer
Aduro joins the exclusive group of companies, so far only the big pharma, that have a successful trail of immunooncology candidates.
HPV Screen Better Predictor of Cervical Cancer Risk Than Pap Test
The researchers found that the risk of developing cervical cancer within three years following a negative HPV test result was about half of the already low risk following a negative Pap test.